+ Main Category
+ Tell a Friend
Fill out the information below to email a friend a brief note about 'Pomology: Fruit Cultivation and Production'
+ Top 10
+ Directory Statistics
Links: 1182
Categories: 54
Registered Users: 178
Mailing List Subscribers: 24
+ Pagerank Statistics
+ Join Mailing List
Joining mailing list will entitle you to receive occasional emails informing you of news and updates to the site and any special offers that may be of interest to you.
Research > Chapter 1051
Bookmarks
Agonist activity 3-hydroxy metabolites tibolone oestrogen receptor mouse n20.1 oligodendrocyte cell line normal human astrocytes.
Agonist administration ovo down-regulates cerebellar GABA-A receptors chick embryo.
Agonist examination 2-(carboxycyclopropyl)glycine isomers cloned metabotropic glutamate receptor subtypes expressed Chinese hamster ovary cells.
Agonist antagonist EMG activation isometric torque progress elbow spastic hemiparesis.
Agonist antagonist actions (-)pindolol recombinant, human serotonin1A (5-HT1A) receptors.
Agonist antagonist actions antipsychotic agents 5-HT1A receptors. (35S)GTPgammaS binding study.
Agonist antagonist actions buprenorphine types opioid receptor extracted preparations.
Agonist antagonist actions yohimbine compared fluparoxan alpha2-adrenergic receptors (AR)s, serotonin (5-HT)1A, 5-HT1B, 5-HT1D dopamine D2 D3 receptors. Significance modulation frontocortical monoaminergic transmission depressive states.
Agonist antagonist activities benzodiazepine receptors series quinoline derivatives.
Agonist antagonist activities ligands derived naltrexone oxymorphone.
Agonist antagonist activities leukotriene analogue BAY u9773 guinea swine lung parenchyma.
Agonist antagonist activities human NPFF2 receptors NPY ligands GR231118 BIBP3226.
Agonist antagonist activity en clomiphene estrogen mediated events uterus pituitary gland brain rat.
Agonist antagonist activity en-clomiphene oestrogen-mediated events uterus, pituitary gland brain rat.
Agonist antagonist binding muscarinic acetylcholine receptors purified porcine brain interconversion high affinity sites sulfhydryl reagents.
Agonist antagonist binding alpha 2 adrenergic receptors purified membranes human platelets implications receptor inhibitory nucleotide binding protein stoichiometry.
Agonist antagonist binding rat brain muscarinic receptors effect aging.
Agonist antagonist binding tachykinin peptide nk 2 receptors.
Agonist antagonist characterization putative adrenoceptor distinct pharmacological properties alpha beta subtypes.
Agonist antagonist effects 15R-prostaglandin (PG) D-2 11-methylene-PGDon human eosinophils basophils.
Agonist antagonist effects 3 3 hydroxyphenyl n propylpiperidine enantiomers functional dopamine autoreceptors postsynaptic dopamine receptors vitro.
Agonist antagonist effects apomorphine enantiomers 5-HT3 receptors.
Agonist antagonist effects benzodiazepines motor performance - effect intrinsic efficacy task difficulty.
Agonist antagonist effects detomidine atipamezole heart rate electrocardiogram dogs.
Agonist antagonist effects histamine H3 receptor ligands 5-HT3 receptor-mediated ion currents NG108-15 cells.
Agonist antagonist interactions 1 dopamine receptors agonist stimulated masking 1 receptors depends intrinsic activity.
Agonist antagonist modulation (35S)-GTP-gamma-S binding transfected CHO cells expressing neurotensin receptor.
Agonist antagonist retinoic acid receptors related gene expression stimulate senescence-like growth arrest MCF-7 breast carcinoma cells.
Agonist antagonist opioid activity axial equatorial conformations S-methyl- S-allyl-morphinans.
Agonist antagonist properties benzazepine thienopyridine derivatives 1 dopamine receptor.
Agonist antagonist properties beta-3-adrenoceptors human omental mouse 3T3-L1 adipocytes.
Agonist antagonist properties dihydroetorphine mu-opioid receptors mice.
Agonist antagonist sensitivity non-selective cation channel currents evoked muscarinic receptor stimulation bovine ciliary muscle cells.
Agonist antagonist specificities decidual prostaglandin-releasing oxytocin receptors myometrial uterotonic oxytocin receptors pregnant rats.
Agonist antagonist-dependent internalization human vasopressin V2 receptor.
Agonist anti mineralo corticoid activities spirono lactones.
Agonist blocking effects choline neuromuscular junction.
Agonist cyclic AMP-mediated regulation beta-1-adrenergic receptor mRNA gene transcription rat C6 glioma cells.
Agonist hypertonic saline-induced trafficking NK3-receptors vasopressin neurons paraventricular nucleus hypothalamus.
Agonist inhibitory effects pyridostigmine neuromuscular junction.
Agonist inverse agonist effects cl 218872 benzodiazepine receptors.
Agonist inverse agonist efficacy human recombinant serotonin 5-HT-1A receptors role receptor:G-protein stoichiometry.
Agonist local anaesthetic properties xylazine.
Agonist membrane depolarization stimulated activation MAP kinase pig carotid artery.
Agonist antagonist activity ergocristine alpha adrenoceptors rat.
Agonist antagonist effects buprenorphine effect potentials frog sciatic nerve fibers.
Agonist antagonist interaction dopamine receptors brain reflected rates tyrosine tryptophan hydroxylation.
Agonist antagonist properties phenoxybenzamine anti nociception opiate dependence tests.
Agonist antagonistic interactions pentazocine morphine studied mice.
Agonist anti-gp130 transducer monoclonal antibodies human myeloma cell survival growth factors.
Agonist antibody Fas ligand mediate diverse sensitivity death signaling pathways Fas cytoplasmic mutants.
Agonist behavior feeding habits starling sturnus vulgaris captivity influence density.
Agonist behavior cardiovascular components elicited microinjection L-glutamic acid basal midbrain toad Bufo paracnemis.
Agonist binding activation rat beta1-adrenergic receptor - function Trp134 (3.28), Ser 190 (4.57) Tyr356 (7.43).
Agonist binding affinity condition transitions reconstituted nicotinic acetylcholine receptors revealed single sequential mixing stopped-flow fluorescence spectroscopies.
Agonist binding protein kinase C activation induce phosphorylation gastrin-releasing peptide receptor distinct sites.
Agonist binding alpha-2-adrenoceptors elevated locus coeruleus victims suicide.
Agonist binding 1 muscarinic receptors sensitive guanine nucleotides.
Agonist binding peptide hormone receptors.
Agonist binding rat brain somatostatin receptors alters interaction receptors guanine nucleotide-binding regulatory proteins.
Agonist binding Torpedo acetylcholine receptor. Complexities revealed dissociation kinetics.
Agonist binding Torpedo acetylcholine receptor. Complexities revealed association kinetics.
Agonist binding Torpedo acetylcholine receptor - Complexities revealed dissociation kinetics.
Agonist phorbol ester stimulated desensitization human lymphocyte prostaglandin receptor dependent tubulin polymerization.
Agonist concentration dependency blocking kinetics balance block N-methyl-D-aspartate receptors memantine.
Agonist dependent generation lipoxins rat basophilic leukemia cell rbl 1.
Agonist dependent phosphorylation cerebral atrial muscarinic receptors blockade phosphorylation gtp binding regulatory proteins reversal guanine nucleotides.
Agonist desensitisation alpha-1 adrenoceptors endothelin-1 receptors coupled phosphatidylinositol metabolism.
Agonist discrimination between AMPA receptor subtypes.
Agonist influence dihydrobenzofurane derivative 9871 stereoisomers pithed rats.
Agonist effects putative 5 ht 4 receptors rat hippocampus dextro levo zacopride proof stereoselectivity.
Agonist effects 2 proline 7 phenylalanine 9 tryptophan agent proof diverse receptors.
Agonist effects beta phenethylamines noradrenergic cyclic amp generating scheme rat limbic fore brain stereo isomers hydroxy norephedrine.
Agonist efficacy receptor efficiency heterozygous CB1 knockout mice - Relationship reduced CB1 receptor density G-protein activation.
Agonist enhanced palmitoylation platelet proteins.
Agonist flare-up antagonist manipulation poor responders undergoing vitro fertilization cure.
Agonist role neurokinin receptor antagonist, (D-Arg1,D-Phe5,D-Trp7,9,Leu11)substance P, monocytes.
Agonist high affinity affinity states 2 dopamine receptor calf brain partial conversion guanine nucleotide.
Agonist high affinity condition ratios predict drug intrinsic activity revised ternary complex mechanism serotonin 5-HT2A 5-HT2C receptors.
Agonist independent inhibition protein activation muscarinic acetylcholine receptor antagonists cardiac membranes.
Agonist independent phosphorylation purified cardiac muscarinic cholinergic receptors protein kinase.
Agonist stimulated affinity alterations a nervous scheme alpha bungaro toxin receptor.
Agonist stimulated mitogen stimulated de sensitization isoproterenol stimulated cyclic amp structure mouse epidermis vivo.
Agonist stimulated beta adrenergic receptor internalization intact human mononuclear leukocytes influence temperature mononuclear leukocyte separation.
Agonist stimulated calcium flux phosphoinositide metabolism aggregation enzyme secretion human neutrophils.
Agonist stimulated calcium mobilization rat submandibular gland aging succeeding chronic propranolol cure.
Agonist stimulated calcium transients cultured smooth muscle cells measurements fura 2 loaded monolayers.
Agonist stimulated intracellular calcium n1e 115 cells differential effects bradykinin carbachol.
Agonist stimulated properties beta adrenergic receptors intact 49 lymphoma cells time dependent affinity receptor agonists.
Agonist stimulated platelet tubulin phosphorylation.
Agonist stimulated conformation alteration neurotensin receptor mechanism Na+ inhibition 125I-NT binding.
Agonist stimulated contractile responses human bronchial muscle vitro effects calcium removal lanthanum py 108068.
Agonist stimulated contraction accumulation inositol phosphates guinea swine detrusor proof muscarinic purinergic receptors raise intracellular calcium diverse mechanisms.
Agonist stimulated contraction rat myometrium calcium free solution manganese.
Agonist induced cytosolic calcium oscillations originate from a specific locus in single hepatocytes
Agonist stimulated desensitization 5 ht 2 receptors cultured calf aortic smooth muscle cells.
Agonist stimulated desensitization adenylyl cyclase y1 adrenocortical tumor cells.
Agonist stimulated desensitization octopamine receptor.
Agonist stimulated desensitization 1 dopamine receptors linked adenylyl cyclase activity cultured ns20y neuroblastoma cells.
Agonist stimulated desensitization 2 dopamine receptors human 79 retinoblastoma cells.
Agonist stimulated desensitization liver alpha 1 receptors implications evaluation pi hydrolysis.
Agonist stimulated desensitization muscarinic acetylcholine receptor rat brain.
Agonist stimulated desensitization muscarinic receptor mediated calcium efflux concomitant desensitization phosphoinositide hydrolysis.
Agonist stimulated desensitization 2 dopamine receptor intermediate lobe rat pituitary gland.
Agonist stimulated regulation muscarinic cholinergic alpha 2 adrenergic receptors inactivation pertussis toxin.
Agonist stimulated endothelium dependent relaxation rat thoracic aorta mediated cyclic gmp.
Agonist stimulated endothelium dependent relaxation histamine contracted bovine carotid artery.
Agonist stimulated fluctuations cytoplasmic calcium primary cultures bovine endothelial cells.
Agonist stimulated frequency modulation calcium oscillations salt gland secretory cells.
Agonist stimulated glycogenolysis rabbit retinal slices cultures.
Agonist stimulated homologous heterologous sensitization 1 2 dependent contraversive turning.
Agonist stimulated hydrolysis phosphoinositides structure 1 2 diacylglycerol adult human keratinocytes.
Agonist stimulated inositol phosphate responses bovine airway submucosal glands.
Agonist stimulated internalization beta adrenergic receptor smooth muscle cell line.
Agonist stimulated intracellular calcium concentration waves calcium stimulated calcium release mammalian vascular smooth muscle cells.
Agonist stimulated isomerization alpha 1 adrenergic receptor kinetic examination broken cell solubilized preparations.
Agonist stimulated isotonic contraction cultured mesangial cells multiple passage.
Agonist stimulated modulation agonist binding alpha 1 adrenoceptors bovine aorta.
Agonist stimulated muscarinic acetylcholine receptor regulation intact rat brain cells.
Agonist stimulated muscarinic cholinergic receptor internalization, recycling degradation cultured neuronal cells - Cellular mechanisms function desensitization.
Agonist stimulated myopathy neuro muscular junction mediated calcium.
Agonist stimulated myosin phosphorylation isometric contraction unloaded shortening airway smooth muscle.
Agonist stimulated oscillations cytoplasmic free calcium concentration single rat hepatocytes.
Agonist stimulated phosphoinositide hydrolysis choroid plexus.
Agonist stimulated phosphorylation immunologically ras similar protein human erythroleukemia cells.
Agonist stimulated platelet adhesion function patients myocardial infarction.
Agonist stimulated redistribution beta adrenergic receptors intact human mononuclear leukocyte redistributed receptors nonfunctional.
Agonist stimulated regulation adrenoceptor subtypes cerebral cortical slices.
Agonist stimulated regulation neuronal nicotinic acetylcholine receptor pc 12 cells.
Agonist stimulated secretions potassium release rat submandibular gland slices.
Agonist stimulated stimulation inositol phosphates primary rabbit retinal cultures.
Agonist stimulated tension determines vascular reactivity anoxia reoxygenation.
Agonist induction conformational selection activation G-protein-coupled receptor.
Agonist induction, conformational selection, mutant receptors.
Agonist inositol trisphosphate stimulated release calcium murine keratinocytes potential link keratinocyte differentiation.
Agonist interaction decentralization supersensitivity nictitating membrane cat.
Agonist interactions hepatic a1- b-adrenergic receptors - affinity-state regulation guanine nucleotides temperature.
Agonist interactions hepatic alpha 1 adrenergic beta adrenergic receptors affinity condition regulation guanine nucleotides temperature.
Agonist interactions calcium pools skinned unskinned canine tracheal smooth muscle.
Agonist interactions 5 ht 3 receptors recognition sites rat entorhinal cortex labelled structurally radioligands.
Agonist interactions beta adrenergic receptors chronic administration desipramine atypical antidepressants iprindole mianserin.
Agonist interactions cardiac muscarinic receptors effects magnesium guanine nucleotides monovalent cations.
Agonist internalization cloned Y1 neuropeptide Y (NPY) receptor Chinese hamster ovary cells shows strong preference NPY, endosome-linked entry rapid receptor recycling.
Agonist lead diagnosis high affinity niacin receptor GPR109a.
Agonist ligands expressed thymic epithelium enhance positive selection regulatory T lymphocytes precursors TCR repertoire.
Agonist character enantiomer 1 hydroxy 3 amino pyrrolid 2 ha 966.
Agonist effects benzodiazepine receptor antagonist ro 15 1788.
Agonist mediated acetyl choline receptor membrane environment.
Agonist mediated conformational muscarinic receptors rat brain.
Agonist mediated conformational solubilized calf forebrain muscarinic acetylcholine receptors.
Agonist mediated structure inositol monophosphate isomers rat cortical prisms.
Agonist mediated regulation alpha 1 adrenergic beta 2 adrenergic receptor metabolism muscle cell line bc 3h 1.
Agonist mediated regulation alpha 1 adrenergic beta 2 adrenergic receptors cloned mdck cells.
Agonist mobilization sarcoplasmic reticular calcium smooth muscle - Functional coupling plasmalemmal Na+/Ca2+ exchanger?
Agonist ethylmaleimide mediated inactivation beta adrenergic receptors molecular aspects.
Agonist occupancy single monomeric element sufficient internalization dimeric beta(2)-adrenoceptor.
Agonist occupation serotonin-1A receptors rat hippocampus prevents inactivation pertussis toxin.
Agonist dihydropyridine receptors, BAYK8644 depresses excitation-contraction coupling myocytes Guinea swine heart.
Agonist proteinase-activated receptor 2 increases painful behavior produced alpha, beta-methylene adenosine 5 -triphosphate.
Agonist peptide cytotoxic T-lymphocyte epitope human carcinoembryonic antigen stimulates production TC1-type cytokines increases tyrosine phosphorylation efficiently cognate peptide.
Agonist pharmacology neuronal alpha-7 nicotinic receptor expressed Xenopus oocytes.
Agonist pharmacology Drosophila GABA receptor splice variants.
Agonist photoaffinity labeling 1 adenosine receptors persistent activation reveals spare receptors.
Agonist potency P2Xreceptors modulated structurally lipids.
Agonist potency measurement patch clamp examination single glutamate receptors.
Agonist potency differentiates G protein activation Ca2+ signalling orexin receptor type 1.
Agonist profile ergometrine ergonovine population postsynaptic alpha adrenoceptors.
Agonist promoted high affinity condition beta adrenergic receptor human neutrophils modulation cortico steroids.
Agonist promoted sequestration beta 2 adrenergic receptor requires regions involved functional coupling.
Agonist properties N,N-dimethyltryptamine serotonin 5-HT2A 5-HT2C receptors.
Agonist properties microbial superantigen peptide.
Agonist properties stable hexapeptide analog neurotensin, N-alpha-MeArg-Lys-Pro-Trp-tLeu-Leu (NT1).
Agonist properties pindolol h5-HT1A receptors coupled mitogen-activated protein kinase.
Agonist properties putative small-molecule somatostatin sst2 receptor-selective antagonists.
Agonist radioligand interactions solubilized porcine atrial 1 adenosine receptor.
Agonist radioligands identifying functional neurotransmitter receptors.
Agonist regulation muscarinic acetyl choline receptors rat spinal cord.
Agonist regulation expression delta opioid receptor NG108-15 cells.
Agonist regulation human platelet prostaglandin 2 receptor.
Agonist answer kinetics N-methyl-D-aspartate receptors neurons cultured rat cerebral cortex cerebellum - Proof receptor heterogeneity.
Agonist answer human extracted posterior ciliary artery.
Agonist responses neuronal nicotinic acetylcholine receptors potentiated class allosterically acting ligands.
Agonist selective protection opioid receptor coupled proteins inactivation 5 fluorosulfonylbenzoylguanosine.
Agonist selectivity species natriuretic peptide receptor-A.
Agonist selectivity oxytocin/vasopressin receptor family - insights challenges.
Agonist selectivity mGluR1 mGluR2 metabotropic receptors. diverse environment related recognition prolonged glutamate conformation.
Agonist self-inhibitory binding site nicotinic acetylcholine receptor.
Agonist sensitive calcium pool pancreatic acinar cell i. permeability properties.
Agonist sensitive calcium pool pancreatic acinar cell ii. characterization reloading.
Agonist special L-type Ca2+-current stimulation ventricular myocytes steroid-like compound.
Agonist special alterations receptor binding affinity solubilization turkey erythrocyte membrane beta adrenergic receptors.
Agonist special special vitro desensitization human lymphocyte beta 2 adrenoceptors.
Agonist special de sensitization leukotriene 4 induced prostaglandin 2 biosynthesis human endothelial cells.
Agonist special de sensitization prostaglandin 2 induced cyclic amp accumulation prostaglandin 1 human fore skin fibroblasts.
Agonist special desensitization shape change platelets.
Agonist special effects guanine nucleotides alpha adrenergic receptors human platelets.
Agonist special effects guanine nucleotides muscarinic cholinergic receptors rat anterior pituitary membranes.
Agonist special effects monovalent divalent cations adenylate cyclase coupled alpha adrenergic receptors rabbit platelets.
Agonist special refractory states bovine platelets disappearance synergism aggregation.
Agonist special reverse regulation muscarinic receptors transition metal ions guanine nucleotides.
Agonist special function sodium proton antiport prostaglandin release microvessel endothelium.
Agonist induced breakdown tritium labeled myo inositol labeled phosphatidyl inositol mouse pancreas.
Agonist stimulated divalent cation entry into single cultured human umbilical vein endothelial cells
Agonist induced inositol polyphosphate structure cerebellum.
Agonist stimulation increases turnover rate b2AR-bound palmitate promotes receptor depalmitoylation.
Agonist stimulation increases turnover rate beta-2AR-bound palmitate promotes receptor depalmitoylation.
Agonist stimulation B1 B2 kinin receptors activation MAP kinase signaling pathway, resulting translocation AP-1 HEK 293 cells.
Agonist stimulation serotonin1A receptor suppression anoxia-induced apoptosis mitogen-activated protein kinase neuronal HN2-5 cells.
Agonist stimulation provokes dendritic axonal dopamine D1 receptor redistribution primary cultures striatal neurons.
Agonist substitution advanced parkinson's disease.
Agonist trafficking Gi/o-mediated alpha2A-adrenoceptor responses HEL 92.1.7 cells.
Agonist antagonist stimulate distinct thermodynamic modes co-factor binding glucocorticoid receptor.
Agonist, antagonist, inverse agonist properties antipsychotics human recombinant 5-HT1A receptors expressed HeLa cells.
Agonist- CPA-induced altitude cytoplasmic free Ca-2+ intact valvular endothelium rabbits.
Agonist- CPA-induced altitude cytoplasmic free Ca2+ intact valvular endothelium rabbits.
Agonist- antagonist-induced plasticity rat 5-HT1A receptor hippocampal cell culture.
Agonist- antagonist-induced sequestration/internalization neuropeptide Y Y1 receptors HEK293 cells.
Agonist- subunit-dependent potentiation glutamate receptors nootropic drug aniracetam.
Agonist-, antagonist-, benzodiazepine-induced structural alpha(1)Met(113)-Leu(132) area GABAreceptor.
Agonist-Driven Progress CD4+CD25+Foxp3+ Regulatory T Cells Requires Second Signal Mediated Stat6.
Agonist-Induced Conformational Changes Thyrotropin-Releasing Hormone Receptor Type I - Disulfide Cross-Linking Molecular Modeling Approaches.
Agonist-Induced State delta-Opioid Receptor That Discriminates Opioid Peptides Opiate Alkaloids.
Agonist-activated ion channels.
Agonist-activated, ryanodine-sensitive, IP-3-insensitive Ca-2+ release channels longitudinal muscle intestine.
Agonist-activated, ryanodine-sensitive, IP3-insensitive Ca2+ release channels longitudinal muscle intestine.
Agonist-antagonist activity anti-estrogens human breast cancer cell line MCF-7 - An theory interaction site distinct estrogen binding site.
Agonist-antagonist characterization 6-cyanohex-2-yne-DELTA-8-tetrahydrocannabinol extracted tissue preparations.
Agonist-antagonist stimulated coactivator corepressor interplay human androgen receptor.
Agonist-antagonist interactions skin - Comparison effects loratadine cetirizine skin vascular responses prick tests histamine agent P.
Agonist-dependence recovery desensitization P2X3 receptors sensitive advance fast downregulation.
Agonist-dependent AT4 receptor internalization bovine aortic endothelial cells.
Agonist-dependent cannabinoid receptor signalling human trabecular meshwork cells.
Agonist-dependent consequences proline alanine substitution transmembrane helices calcitonin receptor.
Agonist-dependent difference mechanisms involved Ca2+ sensitization smooth muscle porcine coronary artery.
Agonist-dependent difference relation cytosolic Ca2+ degree release vascular relaxing factors endothelium rabbit aortic valve.
Agonist-dependent differential effects berberine human platelet aggregation.
Agonist-dependent failure neutrophil role diabetes correlates extent hyperglycemia.
Agonist-dependent immobilization chimeric bombesin/GRP receptors - Dependence c-Src activity dissociation internalization.
Agonist-dependent immobilization chimeric bombesin/GRP receptors - dependence c-Src activity dissociation internalization.
Agonist-dependent inhibition peptide nonpeptide endothelin receptor antagonists rabbit extracted pulmonary artery.
Agonist-dependent internalization D2 receptors - Imaging quantification confocal microscopy.
Agonist-dependent internalization angiotensin II type receptor (AT1) - function C-terminus phosphorylation recruitment beta-arrestins.
Agonist-dependent phosphorylation N-formylpeptide activation peptide constituent C (C5a) chemoattractant receptors differentiated HL60 cells.
Agonist-dependent phosphorylation human muscarinic receptors Spodoptera frugiperda insect cell membranes G protein-coupled receptor kinases.
Agonist-dependent phosphorylation mouse delta-opioid receptor - Involvement G protein-coupled receptor kinases protein kinase C.
Agonist-dependent phosphorylation parathyroid hormone/parathyroid hormone-related peptide receptor.
Agonist-dependent postsynaptic effects opioids miniature excitatory postsynaptic currents cultured hippocampal neurons.
Agonist-dependent regulation functional activity opiate-binding protein extracted rat brain synaptic membranous.
Agonist-dependent trafficking alpha2-adrenoceptor subtypes - Dependence receptor subtype employed agonist.
Agonist-directed signaling serotonin 5-HT2C receptors - Differences serotonin lysergic acid diethylamide (LSD).
Agonist-directed trafficking explaining difference answer pattern naratriptan sumatriptan rabbit usual carotid artery.
Agonist-driven conformational beta-sheet alpha 7 nicotinic receptors.
Agonist-driven progress CD4(+)CD25(+)Foxp3(+) regulatory T cells requires signal mediated STAT6.
Agonist-evoked Ca-2+ mobilization stores expressing inositol 1,4,5-trisphosphate receptors ryanodine receptors cerebellar granule neurones.
Agonist-evoked calcium efflux functionally discrete compartment Xenopus oocytes.
Agonist-evoked inositol trisphosphate receptor (IP3R) clustering dependent formation endoplasmic reticulum.
Agonist-free transformation glucocorticoid receptor human B-lymphoma cells.
Agonist-independent activation metabotropic glutamate receptors intracellular protein Homer.
Agonist-independent alteration beta-adrenoceptor-G-protein-adenylate cyclase scheme equine model recurrent airway obstruction.
Agonist-independent -dependent oligomerization dopamine D2 receptors fusion fluorescent proteins.
Agonist-independent internalization activity C-terminally truncated somatostatin receptor subtype 2 (DELTA349).
Agonist-independent internalization metabotropic glutamate receptor 1a arrestin- clathrin-dependent suppressed receptor inverse agonists.
Agonist-independent localization NOP receptor detergent-resistant membrane rafts.
Agonist-independent modulation L-type Ca currents basal Gs protein activities single guinea swine ventricular myocytes.
Agonist-independent modulation N-type calcium channels ORL1 receptors.
Agonist-independent nuclear localization of the apelin, angiotensin AT1, and bradykinin B2 receptors
Agonist-independent phosphorylation purified cardiac muscarinic cholinergic receptors protein kinase C.
Agonist-independent tonic inhibitory effect G1 adenylate cyclase activity rabbit ventricular myocardium removal pertussis toxin. function empty receptor-mediated G-1 activation.
Agonist-independent, high constitutive activity human melanocortin 1 receptor.
Agonist-induced (35S)GTP-gamma-S binding membranes Spodoptera frugiperda insect cells expressing human D3 dopamine receptor.
Agonist-induced (Ca2+)i waves Ca2+-induced Ca2+ release mammalian vascular smooth muscle cells.
Agonist-induced Ca-2+ transients cultured rat enteric glial cells astrocytes. comparative study.
Agonist-induced Ca2+i waves Ca2+-induced Ca2+ release mammalian vascular smooth muscle cells.
Agonist-induced Down-regulation NMDA receptors cerebellar granule cells culture.
Agonist-induced GTPgamma35S binding mediated human 5-HT2C receptors expressed human embryonic kidney 293 cells.
Agonist-induced T cell receptor down-regulation - Molecular demands dissociation T cell activation.
Agonist-induced actin polymerization required irreversibility platelet aggregation.
Agonist-induced activation non-selective ion current glomerular endothelial cells.
Agonist-induced activation phospholipase D bovine pulmonary artery endothelial cells - Regulation protein kinase C calcium.
Agonist-induced activation releases peroxisome proliferator-activated receptor beta/delta inhibition palmitate-induced nuclear factor-kappa B skeletal muscle cells.
Agonist-induced association p21-ras GTPase-activating protein phosphatidylinositol 3-kinase.
Agonist-induced association tropomyosin protein kinase Ca colonic smooth muscle.
Agonist-induced calcium oxidative stress responses endothelial cells.
Agonist-induced calcium entry correlates STIM1 translocation.
Agonist-induced calcium oscillations depolarized fibroblasts management photoreleased Ins(1,4,5)P3, Ca++, Ca++ buffer.
Agonist-induced calcium answer single human platelets assayed microfluidic device.
Agonist-induced cell surface trafficking intracellularly sequestered D1 dopamine receptor homo-oligomer.
Agonist-induced cell shape regulated secretion rat pancreatic acini.
Agonist-induced (Ca-2+)-i membrane currents single bovine aortic endothelial cells.
Agonist-induced (Ca2+)i membrane currents single bovine aortic endothelial cells.
Agonist-induced conformational thyrotropin-releasing hormone receptor type I - Disulfide cross-linking molecular modeling approaches.
Agonist-induced cyclic ADP ribose production airway smooth muscle.
Agonist-induced cytoplasmic volume cultured rabbit parietal cells.
Agonist-induced cytosolic calcium oscillations originate from a specific locus in single hepatocytes
Agonist-induced desensitization down-regulation opioid receptors alter levels 125I-b-endorphin cross-linked products subcellular fractions NG108-15 cells.
Agonist-induced desensitization down-regulation delta opioid receptors alter levels 125I-beta-endorphin cross-linked products subcellular fractions NG108-15 cells.
Agonist-induced desensitization endocytosis heterodimeric GABAB receptors CHO-K1 cells.